Search
for
Sort by
Research 241–270 of 1000+
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- JAK Inhibitors for Treatment of Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Overview of Alopecia Areata
- Immunopathogenesis and Experimental Models of Alopecia Areata: From Mechanistic Insights to Translational Platforms
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Immunology of alopecia areata
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Genetic Basis of Alopecia Areata
- Endogenous Retinoids in the Pathogenesis of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study
- CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Review of Promising Off-Label Use of Deucravacitinib
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Major Histocompatibility Complex Class I Chain-Related Gene A Polymorphisms and Extended Haplotypes Are Associated with Familial Alopecia Areata
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- An Updated in the Management of Alopecia Areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Management of Alopecia Areata through Unani Medicine
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review